相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Increased expression of α5β1-integrin is a prognostic marker for patients with gastric cancer
J. Ren et al.
CLINICAL & TRANSLATIONAL ONCOLOGY (2014)
Whole-genome sequencing and comprehensive molecular profiling identify new driver mutations in gastric cancer
Kai Wang et al.
NATURE GENETICS (2014)
Prognostic and Putative Predictive Biomarkers of Gastric Cancer for Personalized Medicine
Viktoria S. Warneke et al.
DIAGNOSTIC MOLECULAR PATHOLOGY (2013)
Comprehensive genomic meta-analysis identifies intra-tumoural stroma as a predictor of survival in patients with gastric cancer
Yonghui Wu et al.
GUT (2013)
Randomized phase II study of three doses of the integrin inhibitor cilengitide versus docetaxel as second-line treatment for patients with advanced non-small-cell lung cancer
Christian Manegold et al.
INVESTIGATIONAL NEW DRUGS (2013)
E-cadherin-integrin crosstalk in cancer invasion and metastasis
Marta Canel et al.
JOURNAL OF CELL SCIENCE (2013)
Clinical significance of integrin αvβ6 expression effects on gastric carcinoma invasiveness and progression via cancer-associated fibroblasts
Zhuonan Zhuang et al.
MEDICAL ONCOLOGY (2013)
Expression and significance of IGF-2, PCNA, MMP-7, and alpha-actin in gastric carcinoma with Lauren classification
Rong-Guang Kuang et al.
TURKISH JOURNAL OF GASTROENTEROLOGY (2013)
Validation and Comparison of Anti-αvβ3 and Anti-αvβ5 Rabbit Monoclonal Versus Murine Monoclonal Antibodies in Four Different Tumor Entities
Christine Boeger et al.
APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY (2013)
Expression of the c-Met Proto-Oncogene and Integrin α5β1 in Human Gastric Cardia Adenocarcinoma
Fusheng Chi et al.
BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY (2012)
Targeted Therapy for Gastric Cancer
Elizabeth C. Smyth et al.
CURRENT TREATMENT OPTIONS IN ONCOLOGY (2012)
A novel treatment for glioblastoma: integrin inhibition
Marc C. Chamberlain et al.
EXPERT REVIEW OF NEUROTHERAPEUTICS (2012)
Integrins as therapeutic targets
Simon L. Goodman et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2012)
Matched rabbit monoclonal antibodies against αv-series integrins reveal a novel αvβ3-LIBS epitope, and permit routine staining of archival paraffin samples of human tumors
Simon L. Goodman et al.
BIOLOGY OPEN (2012)
Cohort Study Based on the Seventh Edition of the TNM Classification for Gastric Cancer: Proposal of a New Staging System
Viktoria S. Warneke et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Regulation of glucocorticoid receptor in multiple myeloma by microRNA
Michael Tessel et al.
CANCER RESEARCH (2010)
Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008
Jacques Ferlay et al.
INTERNATIONAL JOURNAL OF CANCER (2010)
Benefit of Adjuvant Chemotherapy for Resectable Gastric Cancer A Meta-analysis
Xavier Paoletti et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2010)
Integrins as Target: First Phase III Trial Launches, but Questions Remain
Andrea Carter
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2010)
Discovering the false discovery rate
Yoav Benjamini
JOURNAL OF THE ROYAL STATISTICAL SOCIETY SERIES B-STATISTICAL METHODOLOGY (2010)
Integrins as therapeutic targets: lessons and opportunities
Dermot Cox et al.
NATURE REVIEWS DRUG DISCOVERY (2010)
Targeting integrins in malignant glioma
Ghazaleh Tabatabai et al.
TARGETED ONCOLOGY (2010)
Adhesion signaling - crosstalk between integrins, Src and Rho
Stephan Huveneers et al.
JOURNAL OF CELL SCIENCE (2009)
Integrin ανβ6 acts as a prognostic indicator in gastric carcinoma
Z. -Y. Zhang et al.
CLINICAL ONCOLOGY (2008)
Cilengitide: an integrin-targeting arginine-glycine-aspartic acid peptide with promising activity for glioblastoma multiforme
David A. Reardon et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2008)
Randomized Phase II Study of Cilengitide, an Integrin-Targeting Arginine-Glycine-Aspartic Acid Peptide, in Recurrent Glioblastoma Multiforme
David A. Reardon et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Cilengitide induces cellular detachment and apoptosis in endothelial and glioma cells mediated by inhibition of FAK/src/AKT pathway
Leticia Oliveira-Ferrer et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2008)
Molecular prognostic factors and new systemic therapies in gastric cancer
F. Lordick et al.
ONKOLOGE (2008)
Overexpression of the αvβ6 Integrin in Endometrial Cancer
Jonathan L. Hecht et al.
APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY (2008)
Overexpression of the αvβ6 integrin in cervical squamous cell carcinoma is a prognostic factor for decreased survival
S. Hazelbag et al.
JOURNAL OF PATHOLOGY (2007)
Cilengitide inhibits proliferation and differentiation of human endothelial progenitor cells in vitro
Sonja Loges et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2007)
Integrin αVβ3 antagonist Cilengitide enhances efficacy of radiotherapy in endothelial cell and non-small-cell lung cancer models
Jeffrey M. Albert et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2006)
Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer
David Cunningham et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Pathology and molecular biology of gastric cancer
Matti Vauhkonen et al.
BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY (2006)
Demystified ... Tissue microarray technology
J Packeisen et al.
JOURNAL OF CLINICAL PATHOLOGY-MOLECULAR PATHOLOGY (2003)
Expression of alpha v integrin family in gastric carcinomas: Increased alpha v beta 6 is associated with lymph node metastasis
A Kawashima et al.
PATHOLOGY RESEARCH AND PRACTICE (2003)
αvβ6 integrin-A marker for the malignant potential of epithelial ovarian cancer
N Ahmed et al.
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY (2002)
Integrins and prostate cancer metastases
M Fornaro et al.
CANCER AND METASTASIS REVIEWS (2001)
分享论文
